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ABSTRACT
Background. New reagents have emerged allowing researchers to assess a growing
number of vaccine-associated immune parameters. Multiplex immunoassay(s) are
emerging as efficient high-throughput assays in malaria serology. Currently, com-
mercial vendors market several bead reagents for cytometric bead assays (CBA) but
relative performances are not well published. We have compared two types of bead-
based multiplex assays to measure relative antibody levels to malarial antigens.
Methods. Assays for the measurement of antibodies to five Plasmodium falciparum
vaccine candidates using non-magnetic and magnetic fluorescent microspheres were
compared for their performances with a Bio-Plex200 instrument. Mean fluorescence
intensity (MFI) was determined from individuals from western Kenya and compared
to known positive and negative control plasma samples.
Results. P. falciparum recombinant antigens were successfully coupled to both non-
magnetic and magnetic beads in multiplex assays. MFIs between the two bead types
were comparable for all antigens tested. Bead recovery was superior with magnetic
beads for all antigens. MFI values of stored non-magnetic coupled beads did not differ
from freshly coupled beads, though they showed higher levels of bead aggregation.
Discussion. Magnetic and non-magnetic beads performed similarly in P. falciparum
antibody assays. Magnetic beads were more expensive, but had higher bead recovery,
were more convenient to use, and provided rapid and easy protocol manipulation.
Magnetic beads are a suitable alternative to non-magnetic beads in malarial antibody
serology.
Subjects Global Health, Immunology, Infectious Diseases, Translational Medicine
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INTRODUCTION
Antibodies to different Plasmodium falciparum antigens have been correlated in multiple
immuno-epidemiological studies with protection from infection (Duarte et al., 2012; Dent
et al., 2012) or disease (Lourembam & Baruah, 2012;Dodoo et al., 2011; Reiling et al., 2010).
Cross-sectional studies of antibodies to one or two antigens have been used as markers to
estimate past malaria exposure (Cook et al., 2012; Cook et al., 2010; Drakeley et al., 2005).
However, such studies have often yielded conflicting results with some demonstrating a
protective effect for antibodies to a specific antigen (Al-Yaman et al., 1996; Ogutu et al.,
2009), while others do not show any association with malaria disease morbidity indicators
(Murungi et al., 2013; Fowkes et al., 2010). Among the possible reasons for the inconsistent
findings are differences in standardization and analytical approaches (Fowkes et al., 2010).
In many aspects, multiplex fluorescent microsphere assays are a more efficient
method to detect plasma antibodies to P. falciparum in comparison to a traditional
ELISA (for example, sample requirements and handling). The capacity to measure
relative levels of antibodies to multiple antigens could ultimately increase uniformity
for comparative reasons. On this front, there has been a surge in the development of
multiplex methodologies as reliable replacements of ELISAs (Cham et al., 2008; Lal et al.,
2005; Verkaik et al., 2008). These assays utilize microsphere beads, which are conjugated
to specific capture reagents, including conjugation-ready bead sets carrying either avidin,
carboxylate groups (COOH) or oligonucleotide adapters (Reslova et al., 2017; Elshal &
McCoy, 2006). Recently, magnetic microspheres (beads) have become available as an
alternative option to non-magnetic beads. Magnetic beads are made of a core of magnetic
material consisting of iron oxide and an internal array of dyes which color code the
beads, thus allowing multiplexing (Verkaik et al., 2008; Dunbar & Li, 2010; Houser, 2012).
Additional similarities and differences between the two bead types are as shown in Table 1.
The introduction of magnetic beads demands validation with a Bio-Plex100/200
instrument that uses laser excitation and digital signal processing technology. No malaria
specific antibody studies have directly compared multiplex assay results obtained from
non-magnetic with the newer, magnetic beads. The purpose of this study was to determine
if antibody quantification assays using magnetic beads provided similar results to assays
using non-magnetic beads on the Bio-Plex200 platform. Additionally, we explored the effect
of long-term storage onMFI values obtained from non-magnetic bead multiplex assays. To
address these objectives, a 5-plex and 9-plex assay were respectively employed to measure
antibodies to P. falciparum vaccine candidate antigens from the plasma of individuals from
western Kenya and North America never exposed to malaria (negative control samples).
MATERIALS AND METHODS
Non-magnetic and magnetic beads
The carboxylated SeroMAPTMmicrospheres (non-magnetic) product numbers: S005, S015,
S025, S030, S040, S045, S050, S055, and S060; and carboxylated MagPlexTM microspheres
(magnetic) beads, product numbers: MC10029-01,MC10036-01,MC10045-01,MC10054-
01 and MC10065-01 were used. Bead stock suspensions were at 1. 25×107 beads mL−1 and
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Table 1 Similarities and differences between non-magnetic andmagnetic beads used in multiplex assays. The left column indicates the charac-
teristic being compared across the two types of beads.
Characteristic Non-magnetic beads Magnetic beads
Provision for a scalable coupling protocol Yes Yes
Size of bead from xMAP technology 5.6 µm spherical beads 6.5 µm spherical beads
Composition and property Polystyrene beads, show a non-magnetic
behavior
Super paramagnetic particles embedded
in a non-magnetic polymer matrix, show
a non-magnetic behavior, unless when
exposed to a magnetizing field.
Ease of processing Centrifugation and vacuum workflow
utilized
Requires magnetic separator
Washing Requires filter plates and vacuum filtra-
tion
Requires an automated Bio-Plex wash
station and/or a simple hand held mag-
netic plate can also be used
Type of assay supported Commercially available and laboratory
developed assays
Commercially available and laboratory
developed assays
were stored at 2–4 ◦C. Both beads and sheath fluid were obtained from Luminex (Austin,
Texas, USA).
Instrumentation
The antibody measurements were performed using a Bio-Plex200 (Bio-Rad, Hercules,
CA, USA). The Bio-Plex200 consists of a Luminex 200 suspension array reader, high-
throughput fluidics system, a microplate platform, monitor and computer operated with
BPM 5.1 software (Bio-Rad). All washing steps of magnetic beads were carried out on a
HydroFlexTM microplate washer (Tecan, Männedorf, Switzerland) using a magnetic plate
carrier, while washing of non-magnetic beads was performed using a millipore vacuum
manifold. Plates were incubated on an IKA micro-titer shaker R©MTS (Wilmington, NC,
USA). During the coupling procedures, the magnetic microspheres were captured using
a DynaMag magnetic separator (Life Technologies AS Oslo, UK). All centrifugation steps
were carried out in an Eppendorf centrifuge.
Plasma samples
For all multiplex bead assays, a plasma pool made of 30 plasma samples from adults living
in a Ugandan area of seasonal malaria transmission (positive control pool samples Idro
et al., 2005) while seven plasma samples from malaria-naive North American individuals
were used as negative controls. To assess the utility of the coupled beads, a broad range
of plasma test samples from 32 individuals from a malaria endemic area of western
Kenya (John et al., 2005) were also used. Comparisons of both coupled bead types were
performed using the same plasma samples. To compare the instrument detection limit
(IDL) between the bead types 8 duplicate serially diluted positive control plasma at the
following dilutions: 1: 50, 1:100, 1:200, 1:400, 1:1,000, 1:2,000, and 1:4,000 were analyzed
by a 5-plex assay—(AMA-1, EBA-175, MSP-1(19), MSP- 1(42) and MSP-3). In addition,
comparison of freshly coupled and 18-months stored coupled beads was performed by use
of Bio-Plex 200. Written informed consent was obtained from the study participants or,
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in the case of minors, from their parent or guardian. Ethical approval was obtained from
Kenya Medical Research Institute National Ethical Review Committee (protocol number
2101) and the Institutional Review Board of University of Minnesota.
P. falciparum recombinant and peptide antigens
The recombinant P. falciparum antigens used for testing were apical membrane antigen-1
(AMA-1, full length ectodomain FVO strain); erythrocyte-binding antigen (EBA-175, non-
glycosylated region II); glutamate rich protein (GLURP, conserved non-repeat N-terminal
region, amino acids 25–514, R0; and repeat C-terminal region, amino acids 705–1178,
R2, 3D7 strain); liver stage antigen (LSA-NRC, C-terminal region, amino acids 1628 to
1909, 3D7 strain); merozoite surface protein-1 (MSP-119, E-KNG variant; MSP-142 FVO
strain); merozoite surface protein-3 (MSP-3, C-terminus, FVO strain) and recombinant
thrombospondin-related adhesion protein (TRAP, 3D7 strain). Recombinant AMA-1,
LSA-NRC and TRAP were expressed in Escherichia coli and provided by David E. Lanar,
Walter ReedArmy Institute for Research. RecombinantMSP-142 andMSP-3were expressed
in E. coli, and EBA-175 was expressed in Pichia pastoris, and provided by David Narum,
National Institutes of Health. Recombinant GLURP-R0 and GLURP-R2 were expressed in
E. coli and provided by Michael Theisen, Statens Seruminstitut, Copenhagen, Denmark.
Recombinant MSP-119 expressed in Saccharomyces cerevisiae, was provided by the Malaria
Research and Reference Reagent Resource Center (Manassas, VA), and originally deposited
there by David Kaslow.
Coupling of recombinant antigens to non-magnetic and magnetic
microspheres
Prior to use, all buffers were brought to room temperature, EDC and Sulfo-NHS were
desiccated at room temperature for approximately 1 h, and both types ofmicrospheres were
vortexed for 30 s then sonicated for 15 s . P. falciparum antigens were directly coupled to
non-magnetic beads and each to a unique bead set, using a previously described procedure
(Ondigo et al., 2012). We determined the optimal amounts of antigen by coupling 612,500
beads to differing amounts (0.5, 1, 2, 5 and 10 µg) of each antigen and the optimal antigen
amount was the amount that yielded the highest average MFI value. The optimal amount
of antigen coupled to beads were: GLURP-R0 and GLURP-R2 was 0.5 µg, MSP- 142
FVO and MSP-3 FVO was 1 µg; AMA-1 FVO and EBA-175 was 2 µg; and for MSP-119
EKNG, LSA-NRC and TRAP were at 10 µg for each of the 612,500 beads. Magnetic
microspheres were coupled to the same amount of P. falciparum antigens as non-magnetic
microspheres, as per the manufacturer’s protocol. Magnetic beads were pelleted using a
magnetic separator.
IgG Cytometric bead assay to P. falciparum antigens coupled to
non-magnetic beads
All reagents and samples were brought to room temperature before use for both types
of beads and plasma samples were diluted before use. Non-magnetic beads were diluted
with PBNT (0.1% BSA, 0.05% Tween 20, 0.05% sodium azide in PBS) and used at a
working concentration of 1,000 beads/region/well. Bead stocks were then combined in a
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15 ml amber conical tube. 96 well-millipore microtiter plates (MABVN 1250, Millipore
corporation, Billerica, MA) were pre-wetted with 100 µl of PBNT/well and aspirated using
a millipore vacuum manifold and 50 µl of working bead solution was transferred to each
well. Plasma samples were thawed at room temperature, mixed and centrifuged at 16,000
g for 3 min then diluted to 1:100 in buffer (1xPBS, 1% BSA, 0.05% Tween 20, 0.05%
sodium azide, 0.5% polyvinyl alcohol, and 0.8% polyvinyl pyrrolidone). Fifty µl of diluted
plasma was added into each well of a microtiter plate in duplicate. The plasma was mixed
with the beads three times by pipetting up and down and the plates incubated in the dark
on a shaking micro- plate shaker (IKA R© MTS, Wilmington, NC, USA) at 600 rpm for
30 s, followed by 300 rpm for 30 min at room temperature (RT). Plates were aspirated
using a millipore vacuum manifold, washed twice with 100 µl/well of PBNT, and beads
resuspended in 50 µl PBNT. Fifty µl of goat anti-human IgG (1:1,000 in PBNT, F (ab‘)2
fragment-R-phycoerythrin (Sigma, P-8047 #SLBH5768V St. Louis, MO) was added to each
well, and incubated in the dark with shaking at 600 rpm for 30 s, followed by 300 rpm for
30 min. Plates were aspirated using a millipore vacuum manifold and washed twice with
100 µl/well PBNT. The beads were resuspended in 100 µl PBNT and finally analyzed on a
Bio-Plex200 (Bio-Rad, Hercules, CA, USA) equipped with Bio-Plex Manager 5.0 software
(Bio-Rad). Samples were analyzed with the following Bio-Plex200 settings: 100 beads per
region, timeout time was set at none, 50 µL sample volume, and DD gate 5,000–2,5000,
default settings and the RP1 target were turned on.
IgG Cytometric bead assay to P. falciparum antigens coupled to
magnetic beads
The magnetic-based assays were carried out according to the protocol as provided by
the manufacturer. Briefly, 50 µl of working bead solution (1,000 beads/region/well) was
transferred to each Greiner 96-well microtiter black, flat bottom plate (Greiner Bio-One,
Frickenhausen, Germany). The beads were incubated in the dark on a microplate shaker
at 600 rpm for 30 s, followed by 300 rpm for 30 min with 1: 100 diluted plasma samples
added in duplicate at room temperature. Wells were washed twice with an automated
HydroFlexTM microplate washer (Tecan, Männedorf, Switzerland) using 100 µl of PBNT,
and beads resuspended in 50 µl PBNT. Fifty µl goat anti-human IgG (1:1,000 in PBNT, F
(ab)2 fragment-R-phycoerythrin was added to each well. Wells were washed twice with 100
µl PBNTwith an automatedmicroplate washer and beads resuspended in 100µl PBNT and
finally analyzed on a Bio-Plex200 (Bio-Rad, Hercules, CA, USA) equipped with Bio-Plex
Manager 5.0 software (Bio-Rad) for median fluorescence intensity (MFI). Analyses were
performed with a minimum count of 100 beads per region as per the manufacturer’s
instructions.
Statistical analysis
After subtraction of the background blank, the mean of results from the duplicate wells was
reported as the median fluorescence intensity minus background (MFI–BG). To obtain
the cut off value for positivity, three standard deviations (SD) were added to the average
MFI of the negative controls. MannWhitney test was used to compare between MFI values
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from non-magnetic and magnetic beads. In addition, Spearman correlation coefficients
(Rho) was used to compare MFI values obtained from stored coupled beads for 18 months
and freshly coupled beads. A P-value of<0.05 was considered to be statistically significant.
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software
Inc., San Diego, CA, USA).
RESULTS
Comparison of MFI values of non-magnetic and magnetic beads by
Bio-Plex200 instrument
To assess the performance of the multiplex assays the range of fluorescence generated was
used as an indicator of the effectiveness of antigen coupling to the beads. The mean MFIs
(SD) ranged from low values (for blanks) to high values (for positive plasma controls)
for both non-magnetic and magnetic beads. These ranges of values suggested successful
coupling reactions for each of the five P. falciparum recombinant antigens to the two bead
types (Table 2). A comparison of the fluorescence generated with the negative controls in
each of the bead types showed that there was no statistical difference between non-magnetic
and magnetic beads, for each of the analyte measured (all P > 0.05) (Table 2).
Instrument Detection Limit of non-magnetic and magnetic beads by
Bio-Plex200 instrument
The instrument detection limit (IDL) was defined as the analyte concentration that would
be required to produce a signal greater than three times the standard deviation of the
noise level (negative controls) by both non-magnetic and magnetic beads. IDL provided
the lowest quantity of an analyte that could be distinguished above the negative control
samples. This experiment provided a proxy measure of accuracy of the two sets of beads
from the raw MFI values generated. Both non-magnetic and magnetic beads exhibited a
wide dynamic range and had the ability to read concentrations down to the minimum
reported concentration for each of the analytes. Most importantly, the two bead types
provided similar detection limits at low plasma concentrations for all analytes (Fig. 1,
Supplemental Information 1).
Comparison of MFI values between non-magnetic and magnetic beads
on a 5-plex assay
A comparison of ranges of MFI values obtained in a range of samples from individuals
from western Kenya and North Americans showed that the two bead types had equivalent
MFI values (Fig. 2, Supplemental Information 1) (all P > 0.05). In addition the number of
positive responders for AMA-1, EBA-175, MSP-119, MSP-142 and MSP-3 IgG antibodies
were almost identical (data not shown).
Comparison of post coupling microsphere recovery for non-magnetic
and magnetic beads
To quantify bead recovery obtainedwe counted the number ofmicrospheres recovered after
the coupling reaction using a cell counter and a hemocytometer and compared this count
with the starting corresponding number of beads multiplied by 100 percent. Bead recovery
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Table 2 MFI values from non-magnetic andmagnetic beads in a 5-plex Bio-Plex assay. MFI values (SD), generated by non-magnetic and magnetic beads for blanks,
negative controls (n= 7) and positive controls (pooled plasma samples) in a 5-plex assay (SD –Standard Deviation).
Analyte AMA-1 EBA-175 MSP-119 MSP-142 MSP-3
Nonmagnetic
beads
Magnetic
beads
Nonmagnetic
beads
Magnetic
beads
Nonmagnetic
beads
Magnetic
beads
Nonmagnetic
beads
Magnetic
beads
Nonmagnetic
beads
Magnetic
beads
Blanks
(SD)
3.0
(1.4)
5.5
(0.7)
1.0
(0)
5.0
(0)
0.5
(0.7)
5.0
(0)
1.0
(0)
3.5
(0.7)
0.5
(0.7)
4.0
(0)
Negative controls
(SD)
13.0
(9.5)
47.5
(60.6)
27.0
(13.6)
48.8
(22.7)
3.9
(2.9)
13.3
(5.5)
15.0
(10.9)
13.5
(7.5)
36.4
(20.8)
25.6
(19.1)
Positive controls
(SD)
7,706.0
(503.5)
5,463.8
(846.1)
6,774.8
(446.5)
4,759.0
(304.8)
7,376.8
(382.2)
4,210.0
(42.4)
8,747.5
(286.4)
4,499.0
(257.4)
385.8
(3.2)
533.3
(48.4)
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Figure 1 Instrument detection limit over a series of plasma dilutions on a 5-plex assay with non-
magnetic andmagnetic beads. The red line indicates cut off for positivity that was determined using
average MFI plus 3 standard deviations of negative controls. Y -axis indicates the linear MFI values while
x- axis is a range of plasma dilutions tested (1: 50 –1:4,000). MFI values of Y -axis for (A–D) range from
0–10,000 while for (E) range from 0–1,500.
Full-size DOI: 10.7717/peerj.6120/fig-1
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Figure 2 LogMFI values of non-magnetic andmagnetic beads in a 5-plex assay. Log MFI values ob-
tained from individuals plasma samples generated using non-magnetic and magnetic beads in a 5-plex as-
say with horizontal lines indicating the median values and the 25th and 75th percentiles (n= 42). The Y -
axis has logarithmic values of MFI, while x-axis indicate the type of beads.
Full-size DOI: 10.7717/peerj.6120/fig-2
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ranged from 63–76% (AMA-1–70%, EBA-175–64%, MSP-1(19)–76%, MSP-1(42)–63%
and MSP-3–66%) for non- magnetic beads. Bead recovery in magnetic beads, ranged from
83–92% (AMA-1–83%, EBA-175–84%, MSP-1 (19)–86%, MSP-1 (42)–89% and MSP-3–
92%). Our findings indicate that magnetic beads had higher yields microsphere recoveries
post-coupling for each of the five coupled P. falciparum antigens. On the contrary, a lower
non-magnetic bead recovery suggested a higher loss of non-magnetic beads during the
coupling process, which ultimately limits the amount available for multiplex serological
assays.
Stability of antigen coupled non-magnetic beads with a Bio-Plex200
instrument
To determine if antigens decoupled from the beads during 18 months storage at 4 ◦C,
antibodies to nine P. falciparum antigens were measured in plasma samples from
individuals from malaria endemic area of western Kenya, using freshly coupled beads
and beads coupled 18 months ago and stored at 4 ◦C during this time. Percentage bead
aggregation between the types was higher in beads that had been stored for 18 months (data
not shown). Freshly coupled beads had similar MFI values to beads that had been stored for
18 months for each of the antibody measured, and all antibody measurements were highly
correlated with Spearman correlation rho values, r for all >0.9 (AMA-1, 0.95; EBA-175,
0.98; GLURP-R0, 0.95; GLURP-R2, 0.98; LSA-NRC, 0.95; MSP-119, 0.99; MSP-142, 0.97;
MSP-3, 0.98; and TRAP, 0.92, (all P > 0.05) Fig. 3, Supplemental Information 1). We did
not measure stability in magnetic beads as these were new to our experiments, and we did
not have storage time to assess longevity of responses. Future experiments are planned to
assess longevity of antigen coupled magnetic beads.
DISCUSSION
This paper shows that non-magnetic and magnetic beads perform similarly when used to
measure antibodies to P. falciparum antigens. Since the two bead assays are comparable
in this respect, other parameters such as ease of use, quick magnetic bead separation and
availability should determine suitability of the assay. For both non-magnetic and magnetic
beads antigen coupling was successful, the non-specific background was low for blank
samples and, the specific signal intensity was high for positive control samples. Also, they
were able to discriminate different concentrations of antibodies on serially diluted test
samples. Above all, the antigen coupled magnetic microspheres had higher efficiency of
bead recoveries. The findings suggest that magnetic bead assays would provide a powerful
tool for detection and quantification of P. falciparum antibodies.
The results show that both types of beads were comparable (Fig. 2). MFI values were
higher with non-magnetic beads compared to magnetic beads for all the analytes except
MSP-3 when positive control samples were analyzed (Table 2). Although a higherMFI does
not necessarily reflect a better or more valid finding, it may provide a broader dynamic
range (Verkaik et al., 2008). Magnetic beads are advantageous for malaria serology due
to their ability to be manipulated easily during couplings and with the development
of automatic washing system; the beads could be trapped on the bottom of the plate
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Figure 3 MFI values of freshly coupled non-magnetic beads and after 18 months of storage at 4◦ C in a
9-plex Bio-Plex assay.MFI values of freshly coupled non-magnetic beads and after 18 months of storage
at 4 ◦C in a 9-plex assay obtained from individual plasma samples in western Kenya, horizontal lines indi-
cating the change in MFI value between the two sets of beads (n = 32). The Y axis scale has a linear MFI
values ranging from 0–10,000 for (A, B, D, F, G, H) and 0–2, 500 for (C) (E) and (I). X-axis indicate the
status of non-magnetic beads.
Full-size DOI: 10.7717/peerj.6120/fig-3
(Table 1). A critical step of bead-based assays is bead recovery. Improvement in percent
bead recovery, maximizes the yield, results in a larger amount of reagents available to
be used when performing the assays and reduction on the analysis time for each plate.
Multiple centrifugation results in significant bead loss, which ultimately increases the cost
of performing the assay. We observed a 13–26% greater bead recovery with magnetic
compared to non-magnetic beads. However, magnetic beads are more expensive compared
to non-magnetic beads (cost for a vial of 1.25× 107 beads/ml, $726.00 vs. $438.00 (Bio-Rad
Corporation) as at the time of this manuscript submission). In addition, coupling magnetic
beads to proteins of interest does not require centrifugation and sedimentation processes.
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Elimination of centrifugation increases bead recoveries and ease of the assay, making
it simple and convenient to the user. Further, use of magnetic beads may overcome
limitations associated with non-magnetic beads such as leaking, clogging of micro-plates
after washing steps and the need for expensive filter plates. Further, development of
automated plate washers for use with magnetic beads further facilitates rapid and accurate
testing and overcomes limitations in effectively washing samples using non-magnetic
beads. In summary, the process of coupling magnetic beads to proteins of interest is more
straightforward and efficient, reduces bead loss, and does not require the use of disposable
filter plates. Although magnetic beads are more expensive than non-magnetic beads, the
price is comparable when considering the efficiency and use of standard microtiter plates.
In a prior study, storage of coupled non-magnetic beads for seven months at 4 ◦C in the
dark resulted in a decrease in MFI, and it was recommended that lyophilization (Cham et
al., 2008) could be a suitable alternative to minimize disassociation of the antigen(s) from
the beads. In this study, coupled non-magnetic beads were stored at 4 ◦C for 18 months
with no significant loss of sensitivity for antibodies to P. falciparum (Fig. 3), suggesting that
at least for these antigens, engagement between the beads and proteins lasts for prolonged
periods at 4 ◦C, though bead aggregation is increased.
Overall, the magnetic based Bio-Plex assays offer a novel multiplexed approach to assess
P. falciparum antibody patterns in humans plasma samples, which will help advance our
understanding of malaria biology and associated host immunological responses. However,
this study had a limited sample size and a few analytes were tested because of design aspects
based on the amount of stored reagents available for use. Future work should assess the
effect of storage of coupled magnetic beads on antibody detection.
CONCLUSIONS
The magnetic beads performed similarly in P. falciparum antibody assays and provide a
suitable alternative to non-magnetic beads for measurement of antibodies to P. falciparum
antigens. In addition, use of magnetic beads provide the capacity to evaluate a higher
number of P. falciparum analytes due to improved bead recoveries.
ACKNOWLEDGEMENTS
We thankDavidNarum,David Lanar,Michael Theisen andMalaria Research andReference
Reagent Resource Center (MR-4) for provision of recombinant antigens used in the testing.
We are also grateful to the study participants and Justin Cresser for editing the manuscript.
We also thank Bio-Rad for their technical support and for providing the automaticmagnetic
washing system.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
This work was supported by grants from the National Institute of Allergy and Infectious
Disease (U01 AI056270) to CCJ, Fogarty International Center (D43 TW0080085) to BNO,
Ondigo et al. (2019), PeerJ, DOI 10.7717/peerj.6120 12/16
and Fogarty International Center, National Institute of Mental Health, and NIH Office of
the Director, Office of Women’s Health and Office of Aids Research (R25 TW009345) to
BNO. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Grant Disclosures
The following grant information was disclosed by the authors:
National Institute of Allergy and Infectious Disease: U01 AI056270.
Fogarty International Center: D43 TW0080085.
Fogarty International Center, National Institute of Mental Health.
Office of Women’s Health and Office of Aids Research: R25 TW009345.
Competing Interests
The director of Kenya Medical Research Institute approved this article for publication. The
authors declare there are no competing interests.
Author Contributions
• Bartholomew N. Ondigo performed the experiments, analyzed the data, contributed
reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed
drafts of the paper, approved the final draft.
• Gregory S. Park contributed reagents/materials/analysis tools, approved the final draft.
• Cyrus Ayieko approved the final draft, critical review.
• Donald D. Nyangahu approved the final draft, critical review, Sourcing for literature.
• Ronald Wasswa performed the experiments, approved the final draft, critical review.
• Chandy C. John conceived and designed the experiments, analyzed the data, contributed
reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed
drafts of the paper, approved the final draft.
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
Ethical approval was obtained from Kenya Medical Research Institute National Ethical
Review Committee (protocol number 2101) and the Institutional Review Board of
University of Minnesota.
Data Availability
The following information was supplied regarding data availability:
The raw data are available in the Supplemental File.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.6120#supplemental-information.
Ondigo et al. (2019), PeerJ, DOI 10.7717/peerj.6120 13/16
REFERENCES
Al-Yaman F, Genton B, Kramer K, Chang S, Hui G, Baisor M, Alpers MP. 1996.
Assessment of the role of naturally acquired antibody levels to Plasmodium falci-
parummerozoite surface protein-1 in protecting Papa New Guinean children from
malaria morbidity. American Journal of Tropical Medicine and Hygiene 54:443–448
DOI 10.4269/ajtmh.1996.54.443.
ChamGK, Kurtis J, Lusingu J, Theander TG, Jensen AT, Turner L. 2008. A semi-
automated multiplex high-throughput assay for measuring IgG antibodies against
Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small
volumes of plasma.Malaria Journal 7:108 DOI 10.1186/1475-2875-7-108.
Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, McCarthy J, Vallely A,
Drakeley C. 2010. Using serological measures to monitor changes in malaria trans-
mission in Vanuatu.Malaria Journal 9:Article 169 DOI 10.1186/1475-2875-9-169.
Cook J, Speybroeck N, Sochanta T, Somony H, SoknyM, Claes F, Lemmens K, Theisen
M, Soares IS, D’Alessandro U, CoosemansM, Erhart A. 2012. Sero-epidemiological
evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmis-
sion patterns over the rainy season in Cambodia.Malaria Journal 11:Article 86
DOI 10.1186/1475-2875-11-86.
Dent AE, Moormann AM, Yohn CT, Kimmel RJ, Sumba PO, Vulule J, Long CA,
NarumDL, Crabb BS, Kazura JW, Tisch DJ. 2012. Broadly reactive antibodies
specific for Plasmodium falciparumMSP-1(19) are associated with the protection
of naturally exposed children against infection.Malaria Journal 11:Article 287
DOI 10.1186/1475-2875-11-287.
Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, Lamptey H, Egyir B, Oduro
AR, Gyan B, Hodgson A, KoramKA. 2011. Antibody levels to multiple malaria
vaccine candidate antigens in relation to clinical malaria episodes in children in
the Kasena-Nankana district of Northern Ghana.Malaria Journal 10:Article 108
DOI 10.1186/1475-2875-10-108.
Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima
R, Lusingu J, Manjurano A, NkyaWM, LemngeMM, Cox J, Reyburn H, Riley EM.
2005. Estimating medium- and long-term trends in malaria transmission by using
serological markers of malaria exposure. Proceedings of the National Academy of Sci-
ences of the United States of America 102:5108–5113 DOI 10.1073/pnas.0408725102.
Duarte J, Herbert F, Guiyedi V, Franetich JF, Roland J, Cazenave PA, Mazier D, Kom-
bila M, Fesel C, Pied S. 2012.High levels of immunoglobulin E autoantibody to 14−
3−3 epsilon protein correlate with protection against severe Plasmodium falciparum
malaria. Journal of Infectious Diseases 206:1781–1789 DOI 10.1093/infdis/jis595.
Dunbar S, Li D. 2010. Introduction to Luminex R© xMAP R© technology and applications
for biological analysis in China. Asia Pacific Biotech 14:26–30.
Elshal MF, McCoy JP. 2006.Multiplex bead array assays: performance evaluation and
comparison of sensitivity to ELISA.Methods 38:317–323
DOI 10.1016/j.ymeth.2005.11.010.
Ondigo et al. (2019), PeerJ, DOI 10.7717/peerj.6120 14/16
Fowkes FJ, Richards JS, Simpson JA, Beeson JG. 2010. The relationship between anti-
merozoite antibodies and incidence of Plasmodium falciparummalaria: a systematic
review and meta-analysis. PLOS Medicine 7:e1000218
DOI 10.1371/journal.pmed.1000218.
Houser B. 2012. Bio-Rad’s Bio-Plex R© suspension array system, xMAP technology
overview. Archives of Physiology and Biochemistry 118:192–196
DOI 10.3109/13813455.2012.705301.
Idro R, Bitarakwate E, Tumwesigire S, John CC. 2005. Clinical manifestations of severe
malaria in the highlands of southwestern Uganda. American Journal of Tropical
Medicine and Hygiene 72:561–567 DOI 10.4269/ajtmh.2005.72.561.
John CC, Moormann AM, Pregibon DC, Sumba PO, McHughMM, NarumDL, Lanar
DE, Schluchter MD, Kazura JW. 2005. Correlation of high levels of antibodies
to multiple pre-erythrocytic Plasmodium falciparum antigens and protection
from infection. American Journal of Tropical Medicine and Hygiene 73:222–228
DOI 10.4269/ajtmh.2005.73.222.
Lal G, Balmer P, Stanford E, Martin S, Warrington R, Borrow R. 2005. Development
and validation of a nonaplex assay for the simultaneous quantitation of antibodies
to nine Streptococcus pneumonia serotypes. Journal of Immunological Methods
296:135–147 DOI 10.1016/j.jim.2004.11.006.
Lourembam SD, Baruah S. 2012. Antibody response to allelic variants of 19 kDa
fragment of MSP-1: recognition of a variant and protection associated with ethnicity
in Assam, India. Vaccine 30:767–773 DOI 10.1016/j.vaccine.2011.11.069.
Murungi LM, Kamuyu G, Lowe B, Bejon P, TheisenM, Kinyanjui SM, Marsh K,
Osier FH. 2013. A threshold concentration of anti-merozoite antibodies is re-
quired for protection from clinical episodes of malaria. Vaccine 31:3936–3942
DOI 10.1016/j.vaccine.2013.06.042.
Ogutu BR, Apollo OJ, McKinney D, OkothW, Siangla J, Dubovsky F, Tucker K,
Waitumbi JN, Diggs C,Wittes J, Malkin E, Leach A, Soisson LA, Milman JB,
Otieno L, Holland CA, PolhemusM, Remich SA, Ockenhouse CF, Cohen J,
Ripley BallouW,Martin SK, Angov E, Ann Stewart V, Lyon JA, Gray Heppner
Jr D,Withers MR, for the MSP-1Malaria VaccineWorking Group. 2009. Blood
stage malaria vaccine eliciting high antigen-specific antibody concentrations
confers no protection to young children in Western Kenya. PLOS ONE 4:e4708
DOI 10.1371/journal.pone.0004708.
Ondigo BN, Park GS, Gose SO, Ho BM, Ochola LA, Ayodo GO, Ofulla AV, John CC.
2012. Standardization and validation of a cytometric bead assay to assess antibodies
to multiple Plasmodium falciparum recombinant antigens.Malaria Journal 11:Article
427 DOI 10.1186/1475-2875-11-427.
Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, ChokejindachaiW,Mi-
chon P, Tavul L, Siba PM, Cowman AF, Mueller I, Beeson JG. 2010. Evidence
that the erythrocyte invasion ligand PfRh2 is a target of protective immunity
against Plasmodium falciparummalaria. Journal of Immunology 185:6157–6167
DOI 10.4049/jimmunol.1001555.
Ondigo et al. (2019), PeerJ, DOI 10.7717/peerj.6120 15/16
Reslova N, Michna V, KasnyM,Mikel P, Kralik P. 2017. xMAP technology: ap-
plications in detection of pathogens. Frontiers in Microbiology 8:Article 55
DOI 10.3389/fmicb.2017.00055.
Verkaik N, Brouwer E, Hooijkaas H, Van Belkum A, VanWamelW. 2008. Comparison
of carboxylated and Penta-His microspheres for semi-quantitative measure-
ment of antibody responses to His-tagged proteins. Journal of Immunol Methods
335:121–125 DOI 10.1016/j.jim.2008.02.022.
Ondigo et al. (2019), PeerJ, DOI 10.7717/peerj.6120 16/16
